Neurology · Hackensack, NJ
NPI
1043287865
Since 2006
Specialty
Neurology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
211 Essex St, Suite 202
Hackensack, NJ, 07601
Phone (201) 488-1515
Groups this clinician bills Medicare through
Medicare paid, 2024
$243K
2,008 services
Medicare patients, 2024
676
Average age 76
Drug cost, 2024
$11.5M
2,833 prescriptions
Company payments, 2025
$149K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mario Vukic was code 99214 (office e&m - established), 786 times for 382 patients. In total Mario Vukic billed 2,008 services in 24 codes, and Medicare paid $243K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 786 | 382 | $99.99 | $79K |
| 95886 Electrical Nerve Conductivity | Office | 262 | 144 | $84.64 | $22K |
| 99213 Office E&M - Established | Office | 250 | 157 | $72.00 | $18K |
| 99204 Office E&M - New | Office | 148 | 148 | $132.97 | $20K |
| 95813 Neurologic | Office | 113 | 113 | $396.21 | $45K |
| 95910 Electrical Nerve Conductivity | Office | 67 | 66 | $149.31 | $10K |
| 93886 Ultrasound - Nonspecific | Office | 65 | 64 | $244.17 | $16K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 64 | 63 | $127.91 | $8,187 |
| 95911 Electrical Nerve Conductivity | Office | 58 | 58 | $185.18 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 33 | 14 | $66.29 | $2,187 |
| 93880 Duplex Scan - Extracranial Arteries | Facility | 29 | 29 | $30.56 | $886 |
| 99215 Office E&M - Established | Office | 25 | 14 | $105.35 | $2,634 |
| 99203 Office E&M - New | Office | 21 | 21 | $91.92 | $1,930 |
| 95909 Electrical Nerve Conductivity | Office | 20 | 19 | $118.28 | $2,366 |
| 93886 Ultrasound - Nonspecific | Facility | 19 | 12 | $36.70 | $697 |
By year: 2022 $280K for 1,948 services; 2023 $266K for 2,059 services; 2024 $243K for 2,008 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mario Vukic prescribed most often to Medicare patients was Memantine Hcl, with 334 prescriptions and refills. In total Mario Vukic wrote 2,833 Medicare prescriptions that cost $11.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 334 | 853 | 95 | $13K |
| Gabapentin Generic | 304 | 647 | 91 | $6,672 |
| Donepezil Hcl Generic | 165 | 442 | 46 | $2,150 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 155 | 155 | 15 | $1.9M |
| Carbidopa-Levodopa Carbidopa/Levodopa | 143 | 321 | 39 | $5,562 |
| Pyridostigmine Bromide Generic | 101 | 265 | 33 | $14K |
| Pregabalin Generic | 94 | 166 | 25 | $2,469 |
| Levetiracetam Generic | 77 | 189 | 17 | $2,070 |
| Quetiapine Fumarate Generic | 59 | 123 | 16 | $1,909 |
| Sodium Chloride 0.9 % Sodium Chloride | 51 | 69 | 12 | $208 |
| Escitalopram Oxalate Generic | 49 | 110 | 16 | $384 |
| Mycophenolate Mofetil Generic | 45 | 69 | Under 11 | $3,660 |
| Vyvgart Hytrulo Efgartigimod-Hyaluronidas-Qvfc | 45 | 46 | 12 | $2.6M |
| Vyvgart Efgartigimod Alfa-Fcab | 44 | 45 | Under 11 | $2.5M |
| Zolpidem Tartrate Generic | 41 | 41 | Under 11 | $206 |
Brand drugs: 488 claims; generic drugs: 2,319 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mario Vukic $149K ($149K in general payments such as food, travel and fees) from 15 companies. The largest payer was Argenx US, Inc. with $61K.
| Company | Payments | Amount |
|---|---|---|
| Argenx US, Inc. ARGX | 88 | $61K |
| UCB, Inc. UCB.BR | 43 | $37K |
| Amgen Inc. AMGN | 27 | $21K |
| Janssen Biotech, Inc. JNJ | 31 | $18K |
| Alexion Pharmaceuticals, Inc. AZN | 25 | $11K |
| Janssen Scientific Affairs, LLC JNJ | 1 | $149 |
| Pfizer Inc. PFE | 3 | $60.64 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $52.18 |
| TG Therapeutics, Inc. TGTX | 2 | $39.24 |
| Abbvie Inc. ABBV | 2 | $33.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.